NASDAQ

TransCode Therapeutics, Inc. (RNAZ)

♥ 558 Thanks from members

Live price chart, market sentiment, and community perspectives for TransCode Therapeutics, Inc. (NASDAQ: RNAZ).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: Health CareIndustry: BiotechnologyFounder: Daniel PeerFounder: Michael GoldbergLeadership: Michael Goldberg (CEO)Holder: Institutional InvestorsHolder: InsidersTTX-MC13RNA Interference Treatments#RNAZ#TransCode Therapeutics#NASDAQ RNAZ#biotech stock#RNA therapeutics